Video Player

Fundamentals of Cancer Research: Introduction and Overview

Dr. Susan Hockfield
Robert J. Silbey
Tyler Jacks
June 7, 2006
Running Time: 39:30
About the Lecture

About the Lecture

This inaugural address lays the groundwork for an 11-part series on MIT’s efforts in cancer research. Susan Hockfield views MIT’s Center for Cancer Research as a central example of how “life sciences are coming into conversation with engineering in a powerful way.” Robert Silbey provides historical background on the notion of faculty ‘short courses’, and positions the Center as “the jewel in the crown of MIT, a spawning ground for scientific discovery and rewards.”

Tyler Jacks introduces the key research areas and scientists who will speak in the succeeding sessions. He offers a thumbnail sketch of cancer as a molecular genetic progression involving sequential alterations in, and the proliferation of, abnormal cells. “Think of a cancer cell like an integrated circuit: the same kinds of complexities in electronic networks also exist within cells,” notes Jacks. Because of work on the human genome, and advances in scientists’ ability to untangle these complex molecular interactions, “We now have the first generation of anti-cancer drugs targeted against molecular alterations in cancer,” says Jacks. Two highly successful drugs have already been derived from MIT research.

In addition, says Jacks, collaboration among biologists, engineers and mathematicians are yielding “a tremendous collection of tools and technologies.” These include tiny probes that enable diagnosis of cancers at earlier stages, nanoparticles that deliver a therapeutic payload directly to cancer cells, and devices that can be implanted in the body.

    Lecture Details

  • Location: 46-3002

“Better understanding of molecular alterations in cancer has translated over the years into the development of better drugs. This is the future. Application of these techniques and others will enable us to treat cancers more widely... more thoroughly and durably, with fewer side effects.”

Tyler Jacks

Related Videos

About the Speakers

About the Speakers

Dr. Susan Hockfield

MIT President
Professor of Neuroscience

Prior to her arrival at MIT in 2004, Susan Hockfield served as Provost at Yale University, where she was also William Edward Gilbert Professor of Neurobiology. She previously served as Dean of Yale's Graduate School of Arts and Sciences.

Hockfield is a fellow of the American Academy of Arts and Sciences, and a member of the American Association for the Advancement of Science.

She earned a B.A. in biology from the University of Rochester in 1973, and a Ph.D. in anatomy and neuroscience from the Georgetown University School of Medicine in 1979.

Robert J. Silbey

Class of 1942 Professor of Chemistry

Robert J. Silbey joined the MIT faculty as an Assistant Professor in 1966. He became Head of the Chemistry Department in 1990-1995. He was appointed Director of the Center for Materials Science & Engineering in 1998. He served as Dean of the School of Science from 2000-2007. Silbey's primary research concerns the theoretical studies of a) the low temperature thermal properties of glasses, b) energy and electron transfer and relaxation in molecular aggregates, c) the optical and electronic properties of conjugated polymers and d) in collaboration with Professor Field, the dynamics of highly vibrationally excited molecules.

Silbey has received numerous teaching awards at MIT, and has lectured extensively throughout the world. He received his Ph.D. from the University of Chicago in 1965.

Tyler Jacks

Director, Center for Cancer Research and David H. Koch Professor of Biology, MIT Investigator, Howard Hughes Medical Institute

Tyler Jacks received his A.B. in biology from Harvard College and his Ph.D. in Biochemistry and Biophysics from the University of California, San Francisco. His graduate work with Harold Varmus involved the mechanism of ribosomal frameshifting in retroviral gene expression. As a postdoctoral fellow with Robert Weinberg at the Whitehead Institute at MIT, Jacks began his work on tumor-suppressor gene function, using gene targeting in the mouse.

Jacks was named the 2005 Simon M. Shubitz Lecturer and Award recipient, and shared the 2005 Paul Marks Prize for Cancer Research awarded by Memorial Sloan-Kettering Cancer Center.

About the Host

About the Host

MIT School of Science